Loading…
Axogen, Inc. is projected to rise to $54.67 by 2027, a +35% move from its current price of $40.58. AXGN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $39.51 | $40.63 | $41.78 | +0.12% |
| Jul 14 | $39.10 | $40.68 | $42.32 | +0.24% |
| Jul 15 | $38.80 | $40.72 | $42.75 | +0.36% |
| Jul 16 | $38.55 | $40.77 | $43.12 | +0.48% |
| Jul 17 | $38.34 | $40.82 | $43.46 | +0.60% |
| Jul 18 | $38.16 | $40.87 | $43.77 | +0.72% |
| Jul 19 | $38.00 | $40.92 | $44.07 | +0.83% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $38.00 | $40.92 | $44.07 | +0.83% |
| Week 2 | $37.16 | $41.26 | $45.82 | +1.68% |
| Week 3 | $36.59 | $41.60 | $47.30 | +2.53% |
| Week 4 | $36.17 | $41.95 | $48.65 | +3.38% |
| Week 5 | $35.84 | $42.30 | $49.93 | +4.25% |
| Week 6 | $35.58 | $42.66 | $51.15 | +5.12% |
| Week 7 | $35.35 | $43.01 | $52.33 | +5.99% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Axogen, Inc. is a healthcare company that develops and commercializes technologies used for peripheral nerve regeneration and repair worldwide.
Its product portfolio includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, Avive+ Soft Tissue Matrix, and Avance Method, along with peripheral nerve tissue recovery and processing steps, donor medical review and release, debridement and other processing steps, packaging, and sterilization.
The company is headquartered in Alachua, Florida, and provides its products to hospitals, surgery centers and military hospitals through independent in-country distributors.
Axogen, Inc. (AXGN) is a healthcare stock currently priced at $40.58 with a market capitalization of $2.16B, and it is ranked 1973.
The 50-day simple moving average is $42.60 and the 200-day simple moving average is $32.34.
The 30-day price range runs from $33.74 to $48.81, with a support level at $38.72 and a resistance at $46.19.
Forecast outlook shows a neutral start in 2026 (avg $40.58, min $28.55, max $62.11, ROI 0) and a bullish path thereafter, with notable upside in 2030 (avg $116.36, min $85.86, max $170.11, ROI 186.7) and into 2040 (avg $411.61, min $260.30, max $701.00, ROI 914.3) and 2050 (avg $954.63, min $535.61, max $1,781.47, ROI 2252.5).
A major floor 29.6% below — a decisive break under it would weaken the trend.
The nearest floor, 4.6% below — buyers have tended to step in here.
The nearest ceiling, 13.8% above — a clean break opens room to run.
A major ceiling 21.5% above — clearing it would confirm fresh momentum.
Key AXGN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AXGN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $43.50 | Sell | $42.92 | Sell |
| MA 10 | $44.32 | Sell | $43.62 | Sell |
| MA 20 | $44.09 | Sell | $43.59 | Sell |
| MA 50 | $42.60 | Sell | $41.90 | Sell |
| MA 100 | $37.98 | Buy | $38.74 | Buy |
| MA 200 | $32.34 | Buy | $33.35 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.37 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -216.27 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.48 | Sell |
| ROC (12) | -9.20 | Sell |
| Bollinger %B (20,2) | -0.15 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.29 | Buy |
| Awesome (5,34) | 0.71 | Buy |
| Ultimate (7,14,28) | 32.60 | Neutral |
| Momentum (10) | -3.91 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 42.18 | Sell |
| ADX (14) | 15.05 | Neutral |
| ATR (14) | 1.20 | Info |
The near-term technical picture is bullish, supported by a bullish overall sentiment.
RSI(14) is 40, while the 50-day SMA is $42.60 and the 200-day SMA is $32.34. The stock trades within a 30‑day range of $33.74 to $48.81, with a nearby support at $38.72 and a nearby resistance at $46.19.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $28.55 | $40.58 | $62.09 | 0% | Neutral | |
| $43.42 | $54.67 | $72.89 | +35% | Bullish | |
| $59.93 | $77.65 | $107.51 | +91% | Bullish | |
| $79.09 | $104.95 | $149.65 | +159% | Bullish | |
| $85.92 | $116.44 | $170.22 | +187% | Bullish | |
| $97.49 | $134.67 | $201.18 | +232% | Bullish | |
| $104.35 | $146.74 | $223.52 | +262% | Bullish | |
| $116.23 | $166.21 | $257.66 | +310% | Bullish | |
| $149.53 | $217.27 | $342.30 | +435% | Bullish | |
| $172.46 | $254.44 | $406.92 | +527% | Bullish | |
| $259.75 | $410.71 | $699.46 | +912% | Bullish | |
| $535.99 | $955.29 | $1,782.67 | +22.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $28.55 | $40.58 | $49.57 | +0.00% |
| August 2026 | $37.41 | $44.18 | $53.60 | +8.87% |
| September 2026 | $38.02 | $45.22 | $55.49 | +2.37% |
| October 2026 | $38.11 | $45.61 | $56.51 | +0.86% |
| November 2026 | $39.63 | $47.69 | $59.56 | +4.55% |
| December 2026 | $40.81 | $49.35 | $62.09 | +3.48% |
Click any year to see its month-by-month AXGN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AXGN to range from $28.55 to $62.09 through 2026. The $40.58 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AXGN price prediction for 2027 points to an average of $54.67 (low $43.42, high $72.89) — a potential gain of +35% on today's $40.58. Momentum favours further upside here.
In 2028, AXGN is projected to trade between $59.93 and $107.51, averaging $77.65 — a potential gain of +91% from today's $40.58. That is up +42% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Axogen, Inc.'s 2029 outlook centres on $104.95, within a $79.09 to $149.65 range. That is up +35% on the projected 2028 average. That marks a +159% change versus current levels. Momentum favours further upside here.
By 2030, AXGN could reach as high as $170.22, with a base case around $116.44 and support toward $85.92 — roughly +187% from $40.58. Buyers look set to stay in control over this stretch.
Expect AXGN to range from $97.49 to $201.18 through 2031. The $134.67 average target implies a +232% move from current prices. That is up +16% on the projected 2030 average. Momentum favours further upside here.
The AXGN price prediction for 2032 points to an average of $146.74 (low $104.35, high $223.52) — a potential gain of +262% on today's $40.58. Buyers look set to stay in control over this stretch.
In 2033, AXGN is projected to trade between $116.23 and $257.66, averaging $166.21 — a potential gain of +310% from today's $40.58. That is up +13% on the projected 2032 average. Momentum favours further upside here.
Axogen, Inc.'s 2034 outlook centres on $217.27, within a $149.53 to $342.30 range. That is up +31% on the projected 2033 average. That marks a +435% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, AXGN could reach as high as $406.92, with a base case around $254.44 and support toward $172.46 — roughly +527% from $40.58. Momentum favours further upside here.
Expect AXGN to range from $259.75 to $699.46 through 2040. The $410.71 average target implies a +912% move from current prices. That is up +61% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AXGN price prediction for 2050 points to an average of $955.29 (low $535.99, high $1,782.67) — a potential gain of +22.5x on today's $40.58. Momentum favours further upside here.
Investing $1,000 in AXGN today (≈ 24.642681 AXGN) could be worth
$23,540.93
+$22,540.93 (+2254%) by 2050 · US Dollar
Based on the average projected AXGN price of $955.29 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AXGNwould be worth at today's price.
$1,000 invested in AXGN on Jul 10, 2025 (≈ 82.987551 AXGN) would be worth
$3,367.63
+$2,367.63 (+236.8%) today · 3.37× · US Dollar
Based on a AXGN entry price of $12.05 vs. today's $40.58.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $45.89 | $884.29 | -11.6% |
| 1 month ago | $41.34 | $981.62 | -1.8% |
| 3 months ago | $31.96 | $1,269.71 | +27.0% |
| 6 months ago | $31.55 | $1,286.21 | +28.6% |
| 1 year ago | $12.05 | $3,367.63 | +236.8% |
| All time (5.0y) ago | $21.39 | $1,897.15 | +89.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AXGN forecast.
Our base-case forecast reaches $81.00 around 2029.
Implied market cap at $81.00: $4.31B
The multi-year forecast shows rising averages and substantial upside across the horizon. By 2030, the average price is projected to $116.36 with a max of $170.11 and a min of $85.86, yielding an estimated ROI of 186.7% and a bullish sentiment.
By 2040, the average is $411.61 with a max of $701.00 and a min of $260.30, delivering an estimated ROI of 914.3% and continuing bullish sentiment. By 2050, the average is $954.63 with a max of $1,781.47 and a min of $535.61, delivering an estimated ROI of 2252.5% and maintaining a bullish outlook.
Tap a question to reveal the answer.
Min $85.86, Avg $116.36, Max $170.11; ROI 186.7%; Sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROIs (e.g., 34.7% in 2027, 91.7% in 2028, 158.8% in 2029, 186.7% in 2030, 232.2% in 2031, 261.8% in 2032, 309.5% in 2033, 436.3% in 2034, 526.9% in 2035, 914.3% in 2040, and 2252.5% in 2050). The 2026 value is neutral with an avg price of $40.58 and ROI of 0%.
Yes. The 2033 max is $257.61 and the 2035 avg is $254.40, with the 2035 max at $406.87, so $250 is within the forecasted range.
Current price $40.58; market cap $2.16B.
30-day range low $33.74; high $48.81.
Axogen, Inc. Community Discussion
0Share your Axogen, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.